What you believe and what you value as an organization matters. Discover the DNA of our firm.
Get to know our teams and the stories of select staff members who share why they choose to work at Sands Capital.
Read about some of the latest events, partnerships, and business highlights from Sands Capital.
From aquaculture to semiconductors, European firms are quietly becoming global leaders in innovation, sustainability, and value creation.
In this episode of What Matters Most, Sands Capital Portfolio Manager and Sr. Research Analyst Danielle Menichella discusses the business’ journey from Taser maker to artificial intelligence-powered software developer.
Our edge is our culture that helps us do the obvious but hard things. We own many high-quality businesses and hold them with discipline over long periods of time.
FPT has harnessed education to drive Vietnam’s digital transformation and human-capital development.
Our philosophy is rooted in the belief that, over time, stock prices will reflect the earnings power and growth of the underlying businesses.
Our latest annual report offers a comprehensive view of how we add value through active stewardship.
Our newest strategy takes an unconstrained approach to seeking the best growth businesses outside of the U.S.
Sands Capital invests in innovative businesses across all stages of the growth spectrum

Partner
2021
RA Capital (2020 - 2021)
Boston, MA | Principal, Tools and Diagnostics
Farcast Biosciences / Mitra Biotech (2015 - 2020)
Woburn, MA | Head of Strategy, Chief Commercial Officer
RA Capital (2015)
Boston, MA | Entrepreneur in Residence
Becton Dickinson (2006 - 2014)
Franklin Lakes, NJ | VP
Serologicals / Upstate Biotechnology (2000 - 2006)
Charlottesville, VA | VP
Pratt & Whitney (1996 - 1998)
Hartford, CT | Manufacturing Engineer
University of Virginia (2000)
MBA | Darden School of Business
Boston University (1995)
BS | Mechanical Engineering
Parker is a partner on the Life Sciences Pulse strategy. He joined Sands Capital in 2021. Parker has 20 years of operational experience with life science tools, diagnostics, and device companies in a range of commercial, development, and general management roles. In those positions, he has been accountable for revenue ranging from launch up to $70 million annually, led acquisitions and integrations, and designed and executed multiple clinical trials. He has been an advisor, investor, and board member for private life science companies since 2015.
Parker received a BS in mechanical engineering from Boston University and an MBA from the UVA Darden School of Business.
Notice for non-US Investors
Sands Capital does not communicate with clients, prospective clients, or the public via WhatsApp or other social messaging platforms. All official communications are sent only through authorized firm channels and are subject to strict policies, procedures and internal controls designed to protect client information and prevent fraud. If you receive a message claiming to be from Sands Capital through an unofficial channel, do not respond and contact your Sands Capital representative or report the incident to law enforcement.